Navigation Links
BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009
Date:1/12/2009

PLYMOUTH MEETING, Pa., Jan. 12 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced that senior executives voluntarily elected certain compensation restrictions in the fiscal years 2008 and 2009. Senior executives rescinded any 2008 bonus payments, and elected to not increase executive salaries while also reducing stock option compensation for 2009. In addition, the Board of Directors voluntarily reduced their stock option compensation for 2009. After consideration of BMP Sunstone's many achievements during 2008 and management's commitment to the Company, this offer was approved by the Compensation Committee of the Board of Directors.

David Gao, Chief Executive Officer of BMP Sunstone, stated, "The year 2008 was a turning point for our Company as we achieved record top and bottom-line financial performance, completed transformative acquisitions with Sunstone and Rongheng, solidified our presence in China's top three pharmaceutical markets of Beijing, Shanghai and Guangzhou, diversified our product offering with exciting new product launches and product approvals, and strengthened our management team across the organization. Despite the Company's significant progress during 2008, the board and management team have decided to take these compensation restrictions in recognition of the current global economic environment. The success achieved in 2008 enables us to enter 2009 in a strong competitive position and to continue growing our business. We remain enthusiastic about the business prospects in China's rapidly growing healthcare sector."

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 50,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BMP Sunstone Receives High Tech Status
2. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
3. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
4. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
5. BMP Sunstone Reports Third Quarter 2008 Financial Results
6. BMP Sunstone Announces Participation in November Investor Conferences
7. BMP Sunstone Announces Participation in September Investor Conference
8. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
9. BMP Sunstone Reports Second Quarter 2008 Financial Results
10. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
11. BMP Sunstone Receives Import Drug License (IDL) from SFDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... and CEO, Jim Joyce . In ... Saturday, Bill Gates warned world leaders that ... nuclear weapons. Mr. Gates expressed his concern, which is ... scientific terrorists have access to the necessary tools to ...
(Date:2/24/2017)... Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), ... announced its financial results for the fourth quarter and fiscal ... Highlights Total sales in the fourth ... increased by 13.6% in USD terms to $77.6 million from ... Gross profit increased by 13.3% to $46.8 million from ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs ... to include an array of biochemical analyses critical for Lead Discovery. The ... hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, and ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
Breaking Biology Technology:
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
Breaking Biology News(10 mins):